{"id":91086,"date":"2026-05-20T17:37:50","date_gmt":"2026-05-20T12:07:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=91086"},"modified":"2026-05-20T17:37:51","modified_gmt":"2026-05-20T12:07:51","slug":"bajaj-healthcare-analyst-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/","title":{"rendered":"Bajaj Healthcare Analyst Review May 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p>This <strong><a href=\"https:\/\/univest.in\/user\/stocks\/bajajhcare\/bajaj-healthcare-ltd-share-price-today\">Bajaj Healthcare<\/a> analyst review<\/strong> for May 2026 covers the key data investors need for BAJAJHCARE at its current price of Rs 715. Bajaj Healthcare (NSE: BAJAJHCARE) is a specialty pharmaceutical and API manufacturer with a market capitalisation of approximately Rs 2,500 crore. The analyst consensus target of Rs 850 implies meaningful upside, and this <strong>Bajaj Healthcare analyst review<\/strong> examines technical levels, business segments, valuation, and key risks for BAJAJHCARE through FY27.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Bajaj_Healthcare_Company_Snapshot_May_2026\" title=\"Bajaj Healthcare Company Snapshot May 2026\">Bajaj Healthcare Company Snapshot May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Analyst_Insight_in_This_Bajaj_Healthcare_Analyst_Review\" title=\"Analyst Insight in This Bajaj Healthcare Analyst Review\">Analyst Insight in This Bajaj Healthcare Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Technical_Analysis_in_This_Bajaj_Healthcare_Analyst_Review\" title=\"Technical Analysis in This Bajaj Healthcare Analyst Review\">Technical Analysis in This Bajaj Healthcare Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Key_Support_and_Resistance_Levels\" title=\"Key Support and Resistance Levels\">Key Support and Resistance Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Business_Segment_Analysis\" title=\"Business Segment Analysis\">Business Segment Analysis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#API_and_Pharmaceutical_Intermediates\" title=\"API and Pharmaceutical Intermediates\">API and Pharmaceutical Intermediates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Nutraceuticals_and_Amino_Acids\" title=\"Nutraceuticals and Amino Acids\">Nutraceuticals and Amino Acids<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Specialty_Vitamins_and_Health_Ingredients\" title=\"Specialty Vitamins and Health Ingredients\">Specialty Vitamins and Health Ingredients<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Valuation_in_This_Bajaj_Healthcare_Analyst_Review\" title=\"Valuation in This Bajaj Healthcare Analyst Review\">Valuation in This Bajaj Healthcare Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Trade_Outlook_for_Bajaj_Healthcare\" title=\"Trade Outlook for Bajaj Healthcare\">Trade Outlook for Bajaj Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Key_Risks_for_Bajaj_Healthcare_in_FY27\" title=\"Key Risks for Bajaj Healthcare in FY27\">Key Risks for Bajaj Healthcare in FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Conclusion_Bajaj_Healthcare_Analyst_Review_Verdict_for_2026\" title=\"Conclusion: Bajaj Healthcare Analyst Review Verdict for 2026\">Conclusion: Bajaj Healthcare Analyst Review Verdict for 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Frequently_Asked_Questions_Bajaj_Healthcare_Analyst_Review_2026\" title=\"Frequently Asked Questions: Bajaj Healthcare Analyst Review 2026\">Frequently Asked Questions: Bajaj Healthcare Analyst Review 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#What_is_the_analyst_target_for_Bajaj_Healthcare_in_2026\" title=\"What is the analyst target for Bajaj Healthcare in 2026?\">What is the analyst target for Bajaj Healthcare in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Is_Bajaj_Healthcare_a_good_investment_at_Rs_715\" title=\"Is Bajaj Healthcare a good investment at Rs 715?\">Is Bajaj Healthcare a good investment at Rs 715?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#What_is_Bajaj_Healthcares_52-week_high_and_low\" title=\"What is Bajaj Healthcare&#8217;s 52-week high and low?\">What is Bajaj Healthcare&#8217;s 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#What_are_the_key_risks_for_Bajaj_Healthcare\" title=\"What are the key risks for Bajaj Healthcare?\">What are the key risks for Bajaj Healthcare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-analyst-review-2026\/#Where_can_I_track_live_data_for_Bajaj_Healthcare\" title=\"Where can I track live data for Bajaj Healthcare?\">Where can I track live data for Bajaj Healthcare?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Bajaj_Healthcare_Company_Snapshot_May_2026\"><\/span><strong>Bajaj Healthcare Company Snapshot May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bajaj Healthcare manufactures APIs, nutraceuticals, and pharmaceutical intermediates for regulated and domestic markets. Its specialty amino acid and vitamin business serves both pharma and nutraceutical end-markets. The table below summarises the key data referenced in this <strong>Bajaj Healthcare analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>BAJAJHCARE<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceuticals &#8211; APIs and Specialty<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 2026)<\/td>\n<td>Rs 715<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,020<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 620<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 2,500 Crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>20x<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus Target<\/td>\n<td>Rs 850<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 1,050<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 600<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Insight_in_This_Bajaj_Healthcare_Analyst_Review\"><\/span><strong>Analyst Insight in This Bajaj Healthcare Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Associate Director <strong>Kunal Singla<\/strong> suggests watching Bajaj Healthcare closely in May 2026. At Rs 715, Kunal Singla flags Pharmaceuticals &#8211; APIs and Specialty sector dynamics as the primary driver for BAJAJHCARE&#8217;s near-term price action. He notes support in the Rs 632 to Rs 679 zone and flags any sustained close above Rs 758 as a positive signal. Kunal Singla&#8217;s perspective on Bajaj Healthcare adds professional analysis to this <strong>Bajaj Healthcare analyst review<\/strong> and is not a buy recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_in_This_Bajaj_Healthcare_Analyst_Review\"><\/span><strong>Technical Analysis in This Bajaj Healthcare Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 715, BAJAJHCARE is trading within its 52-week band of Rs 620 to Rs 1,020. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.<\/p>\n<p>Near-term support is identified in the Rs 632 to Rs 679 band while resistance is seen in the Rs 758 to Rs 782 zone. A sustained move above Rs 758 could open the path toward the analyst consensus target of Rs 850 as outlined in this <strong>Bajaj Healthcare analyst review<\/strong>.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Support_and_Resistance_Levels\"><\/span><strong>Key Support and Resistance Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Support Zone:<\/strong> Rs 632 to Rs 679 &#8211; investors tracking this <strong>Bajaj Healthcare analyst review<\/strong> should watch for stabilisation or a bounce in this range as a potential accumulation signal for BAJAJHCARE.<\/li>\n<li><strong>Resistance Zone:<\/strong> Rs 758 to Rs 782 &#8211; a sustained close above Rs 758 would be a positive breakout signal worth flagging in this <strong>Bajaj Healthcare analyst review<\/strong>.<\/li>\n<li><strong>Medium-Term Target:<\/strong> The analyst consensus of Rs 850 represents the base-case upside scenario in this <strong>Bajaj Healthcare analyst review<\/strong>.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Segment_Analysis\"><\/span><strong>Business Segment Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"API_and_Pharmaceutical_Intermediates\"><\/span><strong>API and Pharmaceutical Intermediates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is the primary revenue and margin driver for Bajaj Healthcare, directly supporting the earnings trajectory toward the consensus target of Rs 850.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Nutraceuticals_and_Amino_Acids\"><\/span><strong>Nutraceuticals and Amino Acids<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This segment adds scale and diversification to Bajaj Healthcare&#8217;s business model and is a meaningful EPS contributor through FY27 and FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Specialty_Vitamins_and_Health_Ingredients\"><\/span><strong>Specialty Vitamins and Health Ingredients<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This represents the medium-term growth frontier for Bajaj Healthcare and a key re-rating catalyst over the next 12 to 24 months.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_in_This_Bajaj_Healthcare_Analyst_Review\"><\/span><strong>Valuation in This Bajaj Healthcare Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 715, Bajaj Healthcare trades at a trailing P\/E of 20x. This <strong>Bajaj Healthcare analyst review<\/strong> presents three scenarios: a bull case of Rs 1,050 on strong earnings delivery and sector tailwinds, a base case of Rs 850 at analyst consensus, and a bear case of Rs 600 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this <strong>Bajaj Healthcare analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target Price<\/th>\n<th>Key Condition<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1,050<\/td>\n<td>Strong earnings delivery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Consensus)<\/td>\n<td>Rs 850<\/td>\n<td>Moderate growth, analyst consensus estimate<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 600<\/td>\n<td>Earnings miss or macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Trade_Outlook_for_Bajaj_Healthcare\"><\/span><strong>Trade Outlook for Bajaj Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Based on the technical and fundamental analysis in this <strong>Bajaj Healthcare analyst review<\/strong>, investors might watch BAJAJHCARE near the support zone of Rs 632 to Rs 679 for potential opportunities. A flag above Rs 758 could suggest improving momentum toward Rs 850. This article uses watch-and-flag language only and does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Bajaj_Healthcare_in_FY27\"><\/span><strong>Key Risks for Bajaj Healthcare in FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A well-rounded <strong>Bajaj Healthcare analyst review<\/strong> must assess downside risks. Key risks for Bajaj Healthcare include a macro slowdown affecting Pharmaceuticals &#8211; APIs and Specialty sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in BAJAJHCARE.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Bajaj_Healthcare_Analyst_Review_Verdict_for_2026\"><\/span><strong>Conclusion: Bajaj Healthcare Analyst Review Verdict for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Bajaj Healthcare analyst review<\/strong> concludes that at Rs 715, BAJAJHCARE offers a defined risk-reward with a consensus target of Rs 850. The 52-week range of Rs 620 to Rs 1,020 provides context on the current entry point. Use this <strong>Bajaj Healthcare analyst review<\/strong> as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on BAJAJHCARE.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_Bajaj_Healthcare_Analyst_Review_2026\"><\/span><strong>Frequently Asked Questions: Bajaj Healthcare Analyst Review 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_for_Bajaj_Healthcare_in_2026\"><\/span><strong>What is the analyst target for Bajaj Healthcare in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The analyst consensus target is Rs 850, with a bull case of Rs 1,050 and a bear case of Rs 600. This <strong>Bajaj Healthcare analyst review<\/strong> recommends monitoring Q1 FY27 earnings for confirmation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Bajaj_Healthcare_a_good_investment_at_Rs_715\"><\/span><strong>Is Bajaj Healthcare a good investment at Rs 715?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 715 with a P\/E of 20x and a consensus target of Rs 850, this <strong>Bajaj Healthcare analyst review<\/strong> is constructive for medium to long-term investors in the Pharmaceuticals &#8211; APIs and Specialty sector. Always consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Bajaj_Healthcares_52-week_high_and_low\"><\/span><strong>What is Bajaj Healthcare&#8217;s 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 52-week high is Rs 1,020 and the 52-week low is Rs 620. At Rs 715, BAJAJHCARE is positioned within this range as detailed in this <strong>Bajaj Healthcare analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Bajaj_Healthcare\"><\/span><strong>What are the key risks for Bajaj Healthcare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Pharmaceuticals &#8211; APIs and Specialty sector, all assessed in this <strong>Bajaj Healthcare analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_live_data_for_Bajaj_Healthcare\"><\/span><strong>Where can I track live data for Bajaj Healthcare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track Bajaj Healthcare&#8217;s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this <strong>Bajaj Healthcare analyst review<\/strong>.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bajaj Healthcare analyst review 2026: CMP Rs 715, MCap Rs 2,500 Cr, PE 20x. Pharmaceuticals &#8211; APIs and Specialty sector technical levels. May 2026.<\/p>\n","protected":false},"author":28,"featured_media":93263,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-91086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779278873:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Bajaj Healthcare Analyst Review 2026: Key Levels and Outlook"],"rank_math_description":["Bajaj Healthcare analyst review 2026: CMP Rs 715, MCap Rs 2,500 Cr, PE 20x. Pharmaceuticals - APIs and Specialty sector technical levels. May 2026."],"rank_math_focus_keyword":["Bajaj Healthcare Analyst Review"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_date":["2026-05-19"],"_thumbnail_id":["93263"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12573"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/20173737\/Bajaj-Healthcare-Analyst-Review.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=91086"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91086\/revisions"}],"predecessor-version":[{"id":93264,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91086\/revisions\/93264"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/93263"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=91086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=91086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=91086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}